ARC^® Fertility Overview

Infertility is a highly personal and emotional subject and it’s a medical problem that is growing. In fact, six million American adults will be touched by infertility this year representing all ages, socioeconomic groups, and genders. Because of the personalized nature of infertility—the inability to conceive or take a baby to term—there is no one […]

Finding the right physician under any circumstances can be a daunting task. A patient who needs help with fertility may be faced with complicated medical decisions. Friends, family, and even the press and the Internet can provide contradictory information, making it extremely important that each patient find the most appropriate physician to advise her, support […]

After months of trying to get pregnant without success, “infertility” is never a word a couple wants to hear from their physician. Today, many couples are gaining hope from improvements for infertility diagnosis and treatment — making the dream of conceiving a child a real possibility. Infertility is a common disease many couples face during […]

Ovulation is perhaps the single most important factor when trying to conceive. Women who have infrequent, irregular, or no ovulation (anovulation) will find that conceiving is either very difficult or downright impossible. Understanding Ovulation Ovulation is when a mature egg is released from the ovary and makes it way through the fallopian tube in anticipation […]

For many in our audience who are not familiar with the science of Reproductive Endocrinology and Infertility maybe you can provide a brief overview? Reproductive Endocrinology and Infertility is a branch of medicine that identifies and treats infertility in both men and women. In the United States, 15 percent of all couples will face fertility […]

The inability to give birth to a child when desired is a very personal and stressful life experience. Many myths surround this area of human life and though medical science has brought about a rapidly growing number of interventions and technologies to assist individuals toward pregnancy, much of it is misunderstood. It is helpful to […]

Infertility is without a doubt a life altering experience. From your self-esteem, to your plans and dreams for the future, relationships with your friends, family and even your spouse can all be affected. Attention is primarily focused on the physical aspects of infertility, and the emotional aspects often go ignored and untreated. People aren’t aware […]

As more women are delaying childbirth and more baby boomers are reaching midlife, the problem of diminished ovarian reserve (DOR) is increasing. This has several major medical consequences including infertility, decreased bone mass with risk of fracture, abnormal uterine bleeding from lack of regular ovulation, and hot flashes. This article will address ovarian reserve testing […]

Numerous studies have repeatedly shown that women athletes who have a low body mass index, (‘BMI’), have a difficult time starting a family. We have found with our patient population that a number of female athletes have a low BMI. This low BMI often translates into fertility problems. In fact studies have shown that approximately12% of infertility cases are due to being underweight or having a low BMI.

Body fat plays a significant role in reproduction. Sex hormones are fat soluble and they are stored in the body’s fat layers. Women that have a low BMI produce a reduced amount of estrogen which can lead to an abnormal menstrual cycle. Amenorrhea, or the lack of a menstrual cycle, is a result of a low BMI.

Ovulatory dysfunction is one of the most common causes of reproductive failure in subfertile and infertile couples. Since the first clinical trial was published in 1961, clomiphene citrate (CC) has been the front-line therapy for ovulation induction. Its use quickly expanded to other empiric indications, such as luteal phase defect and the enhancement of fecundity in unexplained infertility. Failure to respond to CC occurs in up to 20% of cases, which may then require the use of injectable gonadotropins. The drawbacks of this approach are its high cost (both for the medication and the extensive monitoring it requires), risk of the potentially life-threatening ovarian hyperstimulation syndrome (OHSS), and, perhaps most importantly, the significant risk of high-order multiple gestations. Clearly, an inexpensive yet equally efficacious oral alternative would be ideal. Recent research has focused on the successful use of aromatase inhibitors, mainly letrozole, for ovulation induction. The medical team at Georgia Reproductive Specialists has begun incorporating letrozole into treatment plans for appropriately selected patients.